$SPARC share price in focus: Brokerages stay bullish post Q4, see up to 12% upside as profit jumps 26% - Check target

Sun Pharma Share Price Target 2026: Sun Pharmaceutical Industries Ltd. share price will remain in focus after brokerages largely retained a positive stance following its Q4FY26 results, highlighting growth in India and specialty segments despite margin pressures. The company reported a strong 26 per cent year-on-year rise in profit, and several analysts see potential upside of up to 12 per cent in the stock, even as some flagged higher costs and weakness in the US generics business as near-term concerns. Brokerages On Sun Pharma